InsiderFlow

David Raben

BCAX

David Raben serves as officer: Chief Medical Officer at Bicara Therapeutics Inc. Common Stock (BCAX). This page tracks their complete SEC Form 4 insider trading history including stock purchases and sales.

Total Buys

0 trades

$0.00

Total Sells

5 trades

$1.15M

Net Position

Net Seller

$1.15M

Companies Traded

1

BCAX

Active Period

Oct 2025 – Apr 2026

5 total trades

Most Recent

Sell BCAX

Apr 28, 2026 · $125.8K

David Raben's Insider Trading at Bicara Therapeutics Inc. Common Stock (BCAX)

Buys

0 · $0.00

Sells

5 · $1.15M

Total Shares Bought

0

Total Shares Sold

60,500

BCAX Price Chart
Loading chart...
DateTypeValue
Apr 28, 2026 Sell$125.8K
Mar 26, 2026 Sell$104.2K
Mar 5, 2026 Sell$305.6K
Nov 24, 2025 Sell$205.1K
Oct 9, 2025 Sell$405.9K